Gene: TBX18
Official Full Name: T-box transcription factor 18provided by HGNC
Gene Summary: This genes codes for a member of an evolutionarily conserved family of transcription factors that plays a crucial role in embryonic development. The family is characterized by the presence of the DNA-binding T-box domain and is divided into five sub-families based on sequence conservation in this domain. The encoded protein belongs to the vertebrate specific Tbx1 sub-family. The protein acts as a transcriptional repressor by antagonizing transcriptional activators in the T-box family. The protein forms homo- or heterodimers with other transcription factors of the T-box family or other transcription factors. [provided by RefSeq, Nov 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33590 | TBX18 Knockout cell line (HCT 116) | Human | TBX18 | 1:2~1:4 | Negative | Online Inquiry |
KO33591 | TBX18 Knockout cell line (HEK293) | Human | TBX18 | 1:3~1:6 | Negative | Online Inquiry |
KO33592 | TBX18 Knockout cell line (A549) | Human | TBX18 | 1:3~1:4 | Negative | Online Inquiry |
TBX18 Gene Knockout Cell Lines are genetically engineered cell lines that have undergone targeted disruption of the TBX18 gene, which encodes a T-box transcription factor critical for the development and function of various tissues, particularly in the cardiovascular and developmental biology domains. By disabling the TBX18 gene, these cell lines provide researchers with a unique tool to study the gene's functions and its downstream effects on cellular behaviors.
The key mechanism underlying the functionality of TBX18 Gene Knockout Cell Lines is based on the principle of gene editing through CRISPR-Cas9 technology or similar methodologies. This precise editing allows for the elimination of TBX18 expression, thereby permitting in-depth investigations into the gene's role in differentiation, cell signaling pathways, and morphological characteristics under controlled experimental conditions. Such insights are invaluable for elucidating the pathophysiological mechanisms of diseases where TBX18 is implicated.
From a scientific standpoint, these cell lines are instrumental in advancing research aimed at understanding congenital heart defects, tissue regeneration, and developmental disorders. Moreover, they hold promise in drug discovery initiatives, offering a platform for screening small molecules targeting TBX18-related pathways in various cellular contexts.
Compared to traditional models, such as wild-type cell lines or knockout models created via less precise methods, TBX18 Gene Knockout Cell Lines boast higher specificity and reproducibility. This precision reduces the potential for off-target effects and enhances the reliability of experimental outcomes, making them a superior choice for researchers seeking robust data.
For researchers and clinicians focused on cardiovascular research, regenerative medicine, or developmental biology, the availability of these specialized cell lines represents a significant opportunity to manipulate and analyze the TBX18 gene's contributions in a controlled manner.
Our company specializes in cutting-edge genetic and biological products, backed by a robust foundation in molecular biology research and development. We are committed to providing high-quality tools that facilitate breakthrough discoveries, empowering researchers with the resources they need to advance scientific knowledge and improve clinical outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.